ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

GRDX vs GRCE // FREE CASH FLOW YIELD

GridAI Technologies Corp. (NASDAQ) VS. Grace Therapeutics Inc. (NASDAQ) • 15-METRIC TALLY: GRDX 2 — GRCE 2
▲ FREE CASH FLOW YIELD LEADER: GRDX
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (GRDX VS. GRCE) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC GRDX GRCE SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin -30.00% — — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) -20.00% -18.90% -1.10 GRCE /roic <GO>
EV/EBITDA & P/E Valuation — — — TIE /valuation <GO>
Free Cash Flow Yield ACTIVE -14.67% -21.73% +7.06 GRDX /fcf-yield <GO>
Operating Margin -60.00% — — TIE /operating-margins <GO>
Net Profit Margin -60.00% — — TIE /net-margins <GO>
Revenue Growth (YoY) — — — TIE /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity — — — TIE /balance-sheet <GO>
Piotroski F-Score Quality 2/9 2/9 0.00 TIE /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 54.5 46.2 +8.39 GRDX /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $38.9M $40.8M -$1.9M GRCE /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR GRDX REV GRCE REV GRDX GROSS % GRCE GROSS % GRDX FCF GRCE FCF
FY 2025 $36.3K $0 -50.0% — -$5.7M -$8.9M
FY 2024 $0 $0 — — -$9.2M -$14.9M
FY 2023 $0 $0 — — -$12.4M -$12.3M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
GRDX // BETA —
GRCE // BETA —